Hainan Shuangcheng Pharmaceut - Asset Resilience Ratio

Latest as of September 2025: 3.29%

Hainan Shuangcheng Pharmaceut (002693) has an Asset Resilience Ratio of 3.29% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Hainan Shuangcheng Pharmaceut for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥26.22 Million
≈ $3.84 Million USD Cash + Short-term Investments

Total Assets

CN¥797.77 Million
≈ $116.74 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Hainan Shuangcheng Pharmaceut's Asset Resilience Ratio has changed over time. See 002693 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Hainan Shuangcheng Pharmaceut's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Hainan Shuangcheng Pharmaceut worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥26.22 Million 3.29%
Total Liquid Assets CN¥26.22 Million 3.29%

Asset Resilience Insights

  • Limited Liquidity: Hainan Shuangcheng Pharmaceut maintains only 3.29% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Hainan Shuangcheng Pharmaceut Industry Peers by Asset Resilience Ratio

Compare Hainan Shuangcheng Pharmaceut's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Hainan Shuangcheng Pharmaceut (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Hainan Shuangcheng Pharmaceut.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.00% CN¥2.83K
≈ $413.53
CN¥783.87 Million
≈ $114.70 Million
-3.55pp
2023-12-31 3.55% CN¥28.52 Million
≈ $4.17 Million
CN¥803.25 Million
≈ $117.54 Million
-11.14pp
2022-12-31 14.69% CN¥133.81 Million
≈ $19.58 Million
CN¥911.02 Million
≈ $133.31 Million
+8.20pp
2021-12-31 6.48% CN¥55.40 Million
≈ $8.11 Million
CN¥854.56 Million
≈ $125.05 Million
-3.90pp
2020-12-31 10.38% CN¥94.25 Million
≈ $13.79 Million
CN¥907.68 Million
≈ $132.82 Million
+4.83pp
2019-12-31 5.55% CN¥52.80 Million
≈ $7.73 Million
CN¥950.98 Million
≈ $139.16 Million
-6.94pp
2018-12-31 12.50% CN¥139.98 Million
≈ $20.48 Million
CN¥1.12 Billion
≈ $163.93 Million
+1.80pp
2017-12-31 10.69% CN¥147.25 Million
≈ $21.55 Million
CN¥1.38 Billion
≈ $201.52 Million
+10.26pp
2016-12-31 0.43% CN¥5.00 Million
≈ $731.66K
CN¥1.17 Billion
≈ $170.55 Million
+0.21pp
2015-12-31 0.22% CN¥3.37 Million
≈ $493.14K
CN¥1.55 Billion
≈ $226.84 Million
-40.06pp
2014-12-31 40.27% CN¥380.00 Million
≈ $55.61 Million
CN¥943.54 Million
≈ $138.07 Million
--
pp = percentage points

About Hainan Shuangcheng Pharmaceut

SHE:002693 China Drug Manufacturers - Specialty & Generic
Market Cap
$520.65 Million
CN¥3.56 Billion CNY
Market Cap Rank
#12331 Global
#3822 in China
Share Price
CN¥8.58
Change (1 day)
-0.35%
52-Week Range
CN¥6.52 - CN¥9.16
All Time High
CN¥38.37
About

Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmace… Read more